The intersection of substance use with broader public health concerns.
Public Health
Call for papers: International Mental Health Journal
Lanzamiento de Maestría en Consumo de Sustancias Psicoactivas desde una perspectiva Sociosanitaria
Actualmente existe consenso en relación a que cuando un fenómeno se expande en forma epidémica, existen factores de causación social que lo determinan, razón por la cual, la magnitud poblacional del consumo de sustancias debe ser comprendida y abordada desde una perspectivas sociosanitaria que coordine la asistencia socia educativa y sanitaria incluyendo líneas de acción generales y específicas.

Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non–Small Cell Lung Cancer
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada
Clearing the Smoke on Cannabis: Cannabis Use During Pregnancy and Breastfeeding

Effect of Community Support on the Implementation of Primary Health Care-Based Measurement of Alcohol Consumption
New Psychoactive Substances (NPS): Synthetic Hallucinogens/ Synthetic Depressants
New Psychoactive Substances (NPS): Synthetic Hallucinogens/ Synthetic Depressants

The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers will report the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provides evidence on how the three smoking cessation pharmacotherapies available in Australia (nicotine replacement therapy, varenicline and bupropion) compare to each other in terms of cardiovascular safety.